| Document |
Document Title |
|
WO/2021/140761A1 |
The purpose of the present invention is to provide a radiation-sensitive resin composition and a resist pattern formation method, which enable formation of a resist pattern having excellent LWR performance and CDU performance and having ...
|
|
WO/2021/141356A1 |
The present invention provides: a compound represented by chemical formula 1; an organic electronic element comprising a first electrode, a second electrode, and an organic layer between the first electrode and the second electrode; and ...
|
|
WO/2021/134820A1 |
Disclosed are a new organic electroluminescent compound and an organic electroluminescent device. The structural formula of the organic electroluminescent compound is as shown below: (I), wherein L1 and L2 are phenylene, and L1 and L2 ma...
|
|
WO/2021/136197A1 |
The present application relates to the technical field of organic materials, and provides a nitrogen-containing compound, an electronic element and an electronic device. The structure of the nitrogen-containing compound is shown as chemi...
|
|
WO/2021/135207A1 |
Disclosed are a nitrogen-containing compound as represented by chemical formula 1, an electronic component, and an electronic device, the nitrogen-containing compound being capable of improving the performance of the electronic component...
|
|
WO/2021/132995A1 |
The present specification relates to an organic light-emitting element comprising compound (A) expressed by chemical formula 1, and compound (B) expressed by any one among chemical formulae 2 to 4.
|
|
WO/2021/129724A1 |
The present invention relates to an arylamine compound and an organic electroluminescent device. The arylamine compound has a structure represented by the formula (1), and contains N atoms rich in electrons and a numer of large conjugate...
|
|
WO/2021/132930A1 |
The present specification provides a heterocyclic compound represented by chemical formula 1, an organic light-emitting device comprising same, a composition for an organic material layer of an organic light-emitting device, and a method...
|
|
WO/2021/122975A1 |
The present disclosure relates to substituted thiophene carboxamides derivatives, their use for controlling phytopathogenic microorganisms and compositions comprising thereof.
|
|
WO/2021/120835A1 |
Provided is the nitrogen-containing compound shown in chemical formula 1, an organic electroluminescent device, and an electronic apparatus, relating to the technical field of organic materials. The nitrogen-containing compound can impro...
|
|
WO/2021/127301A1 |
4-phenyl-N-(phenyl)thiazol-2-amine and 4-(pyridin-3-yl)-N-( phenyl) thiazol-2-amine derivatives and the corresponding thiadiazole, thiophene, oxazole, oxadiazole, imidazole and triazole derivatives and related compounds as aryl hydrocarb...
|
|
WO/2021/123051A1 |
The present disclosure relates to substituted thiophene carboxamides derivatives of formula (I) adn (II), their use for controlling phytopathogenic microorganisms and compositions comprising thereof.
|
|
WO/2021/121230A1 |
A compound represented by formula (I), an application thereof, and an organic electroluminescent device containing same. When the compound is used in an organic electroluminescent device, the luminous efficiency can be improved, the star...
|
|
WO/2021/121022A1 |
A negative dielectric liquid crystal compound, a preparation method therefor, and an application thereof. The compound has a structure as shown in general formula (I): the main chemical structure is dibenzothiophene or dibenzofuran. Such...
|
|
WO/2021/122976A1 |
The present disclosure relates to substituted thiophene carboxamides derivatives, their use for controlling phytopathogenic microorganisms and compositions comprising thereof.
|
|
WO/2021/123237A1 |
The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain 2-amino-N-(amino-oxo-aryl-λ6- sulfanylidene)acetamide compounds (referred to herein as ANASIA co...
|
|
WO/2021/125834A1 |
The present invention provides: a novel compound capable of improving the light-emitting efficiency, stability and lifespan of an element; an organic electrical element using same; and an electronic device thereof.
|
|
WO/2021/117710A1 |
An organic electroluminescent element which comprises a positive electrode, a negative electrode and a light emitting layer that is arranged between the positive electrode and the negative electrode, wherein: the light emitting layer con...
|
|
WO/2021/113679A1 |
The present disclosure relates to dimeric STING agonists of Formulae (I), (II), (III), (IV), (V), and (VI), and pharmaceutically acceptable salts thereof. The present disclosure also relates to methods of preparing the compounds and meth...
|
|
WO/2021/113809A1 |
The present disclosure relates to heterocyclic compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating dis...
|
|
WO/2021/111912A1 |
The purpose of the present invention is to provide a radiation-sensitive resin composition that exhibits a good sensitivity to exposure light and an excellent LWR performance and CDU performance, a method for forming resist patterns, a p...
|
|
WO/2021/111913A1 |
The purpose of the present invention is to provide: a radiation-sensitive resin composition which gas good sensitivity with respect to exposure light and is capable of forming a resist pattern that has high water repellency and few defec...
|
|
WO/2021/113808A1 |
The present disclosure relates to heterocyclic compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating dis...
|
|
WO/2021/105069A1 |
Compounds of the formula I in which R1, R2, R3, R4, R5, n and m have the meanings indicated in Claim 1, are inhibitors of HIF-2α, and can be employed for the treatment of diseases such as cancer.
|
|
WO/2021/108282A1 |
The disclosure provides recording materials including aromatic substituted methane-core derivatized monomers and polymers for use in volume Bragg gratings, including, but not limited to, volume Bragg gratings for holography applications....
|
|
WO/2021/102569A1 |
This disclosure relates generally to cannabinoid derivatives of formula (I), pharmaceutical compositions comprising them, and methods of using the cannabinoid derivatives for the treatment of conditions associated with cannabinoid receptor.
|
|
WO/2021/104503A1 |
Disclosed is a method for preparing β-carbonyl sulfone. The method comprises: by taking an α-carbonyl diazo compound and sodium arylsulfinate as reaction substrates, cheap silver nitrate as an optimal catalyst, 1,10-phenanthroline as a...
|
|
WO/2021/107030A1 |
This compound is represented by formula (12X). In formula (12X), Py1 and Py2 each independently represent a substituted or unsubstituted 1-pyrenyl group, and L1 and L2 each independently represent a substituted or unsubstituted phenylene...
|
|
WO/2021/100654A1 |
A compound which is represented by formula (1). (In the formula, R1 represents a hydrogen atom or a methyl group; R2 represents an optionally substituted aromatic ring group or an alkyl group that is substituted by an optionally substitu...
|
|
WO/2021/093172A1 |
The present invention provides an anti-HBV compound, a pharmaceutically acceptable compound or stereoisomer thereof, a preparation method therefor, and use thereof for treating, eradicating or inhibiting HBV infection or for relieving li...
|
|
WO/2021/094974A1 |
The invention relates to a compound of formula (I) or a stereoisomer thereof, or a salt of any of the foregoing and to processes for its preparation. The compounds of formula (I) are useful in the treatment TRPML1- mediated disorders or ...
|
|
WO/2021/088920A1 |
A nitrogen-containing ring derivative regulator, a preparation method therefor and use thereof. In particular, the present invention relates to a compound as represented by general formula (I), a preparation method therefor, a pharmaceut...
|
|
WO/2021/082504A1 |
A nitrogen-containing compound represented by formula I, an electronic element, and an electronic device, relating to the technical field of organic materials. The nitrogen-containing compound can improve the performance of the electroni...
|
|
WO/2021/082714A1 |
The present application provides a nitrogen-containing compound as represented by formula I, an electronic component and an electronic device, belonging to the technical field of organic materials. The nitrogen-containing compound can im...
|
|
WO/2021/083319A1 |
A class of xanthine oxidase (XO) inhibitors, and application thereof in the preparation of drugs for treating XO-related diseases. Specifically disclosed is a compound represented by formula (I) and a pharmaceutically acceptable salt the...
|
|
WO/2021/087084A1 |
Small molecule compounds and corresponding dimers having inhibitory activity against pre-miR-21 RNA and related methods for treatment of neoplastic disease such as cancer and especially cancers expressing miR-21 are disclosed.
|
|
WO/2021/085817A2 |
Provided is a tertiary amine derivative which effectively absorbs a high-energy external light source in the UV region, and thus minimizes damages to organic materials in an organic electroluminescent device, thereby contributing to a su...
|
|
WO/2021/083060A1 |
The present invention relates to a five-membered heterocyclic oxocarboxylic acid compound and the medical use thereof. Specifically, the present invention relates to a compound as represented by formula (I) and a pharmaceutically accepta...
|
|
WO/2021/083018A1 |
The present invention relates to a preparation method for and application of a 3-substituted chiral spiro aminophosphine ligand on a pyridine ring. The 3-substituted chiral spiro aminophosphine ligand on a pyridine ring is a compound sho...
|
|
WO/2021/082958A1 |
Provided is nitrogen-containing compounds represented by formula I-A, electronics and electronic devices. The application belongs to the field of organic material. The nitrogen-containing compounds can improve the performance of electron...
|
|
WO/2021/080015A1 |
Disclosed is a compound of formula (I): wherein all symbols are defined in the description. Also disclosed are pharmaceutical compositions comprising the compounds, methods of making the compounds, kits comprising the compounds and metho...
|
|
WO/2021/080280A1 |
The present specification pertains to: a heterocyclic compound represented by chemical formula 1; and an organic light-emitting device comprising same.
|
|
WO/2021/068950A1 |
Disclosed in the present invention are an amide compound and the medical use thereof as a STING inhibitor. Specifically, disclosed is a compound represented by formula I or formula II, or a pharmaceutically acceptable salt or ester or so...
|
|
WO/2021/070963A1 |
The present invention provides a compound for further improving the performance of an organic EL element, an organic electroluminescent element in which element performance is further improved, and an electronic device that includes such...
|
|
WO/2021/070964A1 |
Provided are: a compound which further improves the performance of organic EL elements; an organic electroluminescent element which has performance that is further improved; and an electronic device which includes such an organic electro...
|
|
WO/2021/070965A1 |
Provided are a compound that further improves the performance of organic EL elements, an organic electroluminescent element having further improved element performance, and an electronic device including such an organic electroluminescen...
|
|
WO/2021/069184A1 |
The present invention relates to a compound of formula (I), to the use thereof in electronic devices, to methods for producing said compound, and to electronic devices containing the compound.
|
|
WO/2021/065350A1 |
Provided are: a radiation-sensitive resin composition having excellent performance in terms of sensitivity, LWR, etc., in an exposure step even when a next-generation exposure technique is applied; and a method for forming a resist patte...
|
|
WO/2021/065893A1 |
The purpose of the present invention is to provide a novel low-molecular-weight compound that exhibits agonistic activity on an orexin receptor and is expected to be useful as a prophylactic or therapeutic agent for narcolepsy and the li...
|
|
WO/2021/063347A1 |
Provided are a new impurity compound of rotigotine behenate, and the rotigotine behenate or a preparation thereof containing less than 0.5% by weight of the impurity compound, and an application of the impurity compound as a reference su...
|
